loadpatents
Patent applications and USPTO patent grants for Han; Xiaochun.The latest application filed is for "substituted pyridotriazine compounds and uses thereof".
Patent | Date |
---|---|
Substituted Pyridotriazine Compounds And Uses Thereof App 20220267343 - Chu; Hang ;   et al. | 2022-08-25 |
Imidazopyrimidine Derivatives App 20220241281 - Chin; Gregory ;   et al. | 2022-08-04 |
Thienopyrimidine derivatives as ACC inhibitors and uses thereof Grant 11,352,371 - Bates , et al. June 7, 2 | 2022-06-07 |
HIV protease inhibitors Grant 11,352,329 - Cai , et al. June 7, 2 | 2022-06-07 |
Imidazopyrimidine derivatives Grant 11,179,397 - Chin , et al. November 23, 2 | 2021-11-23 |
Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use Grant 11,084,832 - Chu , et al. August 10, 2 | 2021-08-10 |
Hiv Protease Inhibitors App 20210078959 - Cai; Zhenhong R. ;   et al. | 2021-03-18 |
Thienopyrimidine Derivatives As Acc Inhibitors And Uses Thereof App 20210053990 - Bates; Jamie G. ;   et al. | 2021-02-25 |
Bridged Tricyclic Carbamoylpyridone Compounds And Their Pharmaceutical Use App 20200317689 - Chu; Hang ;   et al. | 2020-10-08 |
HIV protease inhibitors Grant 10,774,053 - Cai , et al. Sept | 2020-09-15 |
Imidazopyrimidine Derivatives App 20200108071 - Chin; Gregory ;   et al. | 2020-04-09 |
Hiv Protease Inhibitors App 20190210978 - Cai; Zhenhong R. ;   et al. | 2019-07-11 |
Therapeutic Compounds App 20180127388 - Babaoglu; Kerim ;   et al. | 2018-05-10 |
Antiproliferative benzo [B] azepin-2-ones Grant 9,611,224 - Han , et al. April 4, 2 | 2017-04-04 |
Substituted hetero-azepinones Grant 9,394,263 - Donnell , et al. July 19, 2 | 2016-07-19 |
Therapeutic Compounds App 20160015690 - Babaoglu; Kerim ;   et al. | 2016-01-21 |
Substituted Hetero-azepinones App 20150361059 - Donnell; Andrew F. ;   et al. | 2015-12-17 |
Antiproliferative Benzo [b] Azepin-2-ones App 20150353499 - Han; Xiaochun ;   et al. | 2015-12-10 |
Therapeutic compounds Grant 8,987,250 - Babaoglu , et al. March 24, 2 | 2015-03-24 |
Inhibitors of bruton's tyrosine kinase Grant 8,940,741 - Berthel , et al. January 27, 2 | 2015-01-27 |
Therapeutic Compounds App 20130281433 - Babaoglu; Kerim ;   et al. | 2013-10-24 |
Inhibitors of JNK Grant 8,536,172 - Gong , et al. September 17, 2 | 2013-09-17 |
Inhibitors Of Bruton's Tyrosine Kinase App 20130178461 - Berthel; Steven Joseph ;   et al. | 2013-07-11 |
Inhibitors of bruton's tyrosine kinase Grant 8,481,540 - Berthel , et al. July 9, 2 | 2013-07-09 |
JNK modulators Grant 8,399,462 - Dunn , et al. March 19, 2 | 2013-03-19 |
Pyrimidinyl pyridone inhibitors of kinases Grant 8,268,840 - Brookfield , et al. September 18, 2 | 2012-09-18 |
Inhibitors of JNK Grant 8,183,254 - Arzeno , et al. May 22, 2 | 2012-05-22 |
Inhibitors of Bruton's Tyrosine Kinase App 20120040949 - Berthel; Steven Joseph ;   et al. | 2012-02-16 |
Inhibitors of JNK App 20110034470 - Gong; Leyi ;   et al. | 2011-02-10 |
Inhibitors of JNK App 20090318484 - Arzeno; Humberto Bartolome ;   et al. | 2009-12-24 |
Pyrimidinyl pyridone inhibitors of kinases App 20090270389 - Brookfield; Frederick ;   et al. | 2009-10-29 |
JNK modulators App 20080146565 - Dunn; James Patrick ;   et al. | 2008-06-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.